Sector: Healthcare
Replimune is a biotechnology company developing oncolytic immunotherapies designed to treat cancer by stimulating the immune system and directly targeting tumors.
We are tracking 1 layoff event for Replimune as of Apr 11, 2026.
Replimune reduces its workforce and scales back U.S. manufacturing after the FDA declines to approve its lead asset, RP1, for melanoma.
Healthcare
French biopharmaceutical firm Valneva is cutting up to 15% of its global workforce, impacting over 100 employees, following a significant revenue drop and
May 18, 2026
Read storyHealthcare
Takeda is implementing a global "transformation program" to streamline operations and cut costs, resulting in 4,500 job reductions worldwide.
May 14, 2026
Read storyHealthcare
INTEGRIS Health in Oklahoma confirms upcoming workforce reductions and clinic closures due to anticipated Medicaid and Medicare funding cuts.
Apr 17, 2026
Read storyHealthcare
Greenwood Leflore Hospital in Mississippi issued a WARN notice, warning employees of potential layoffs as the hospital prepares to close on June 15.
Apr 14, 2026
Read story